Gastrointestinal Stromal Tumor (GIST) Market Outlook: Size, Trends, and Growth Strategies The gastrointestinal stromal tumor (GIST) industry is witnessing significant advancements driven by innovative therapeutics and evolving treatment paradigms. Increased diagnosis rates and growing awareness about targeted therapies have shaped the current landscape. In-depth analysis of market drivers and restraints reveals promising growth trajectories aligned with expanding patient populations and improved healthcare infrastructure. Market Size and Overview The gastrointestinal stromal tumor (GIST) market is estimated to be valued at USD 1.32 Bn in 2025 and is expected to reach USD 2.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032. This robust growth is driven by advancements in personalized medicine and rising investment in oncology treatment development. The market analysis highlights increasing market revenue from novel approaches targeting specific mutations associated with GIST. Market insights suggest expanding industry share due to rising diagnosis rates worldwide, impacting overall Gastrointestinal Stromal Tumor Market Scope positively. Source link:https://www.coherentmi.com/industry-reports/gastrointestinal-stromal-tumor-gist-market